Thursday, October 23, 2014 Last update: 4:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

AIBioTech Teams with Leidos for Air Force Contract

Companies mentioned in this article: AIBioTech

RICHMOND, Va. -- (BUSINESS WIRE) -- AIBioTech®, a comprehensive contract research organization, is pleased to announce that it is acting as a subcontractor to Leidos, which was awarded a contract by the U.S. Air Force to provide research, development, testing and evaluation for Homeland Defense and Security Technical Area Tasks (HD TAT) to the Department of Defense (DoD) community of interest. Leidos is a national security, health and engineering solutions company. The cost-plus-fixed-fee, firm-fixed-price, multiple-award, indefinite-delivery/indefinite-quantity contract has a one-year base period of performance, four one-year options and a total value of approximately $900 million if all options are exercised. Leidos is one of 12 contractors eligible to compete for task orders under the contract.

The DOD Information Analysis Centers (IACs), administered by the Defense Technical Information Center, operate a portfolio of task order contracts for technical research and analysis. Under the contract, the Leidos team will provide research, development, test and evaluation and advisory and assistance services related to research and development efforts within the chemical, biological, radiological and nuclear defense, homeland defense and security, critical infrastructure protection, weapons of mass destruction, biometrics, medical, cultural studies and alternative energy focus areas. The scope of work under the contract will encompass new and emerging adversary threats that could degrade U.S. (and allied) capabilities, new or extended capabilities in existing military systems and new technology applications to military problems.

“AIBioTech’s strengths in understanding and addressing issues of biodefense and its recognized expertise in state-of-the-art life science technologies were major factors in our selection to the Leidos team,” said Robert B. Harris, President and CSO of AIBioTech and Program Manager at AIBioTech for the new contract effort. “We are pleased to support the efforts of Leidos in meeting the challenges presented by DTIC.”

About AI BioTech

AIBioTech is a comprehensive contract research organization which provides integrated research and development services and clinical testing to physicians and life science investigators in biotechnology and pharmaceutical companies, academic institutions, and in several different government agencies. Its services are offered individually or can be integrated to support product development from discovery to market with full regulatory support. Learn more about AIBioTech at www.aibiotech.com.


Copyright © Business Wire 2014
Contact:

AIBioTech®
Dr. Robert B. Harris, President, and CSO
804-915-3840
Fax: 804-915-3830